Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Suarez-Pinzon, W.
Right arrow Articles by Rabinovitch, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Suarez-Pinzon, W.
Right arrow Articles by Rabinovitch, A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Diabetes, Vol 48, Issue 1 21-28, Copyright © 1999 by American Diabetes Association


ARTICLES

Beta-cell destruction in NOD mice correlates with Fas (CD95) expression on beta-cells and proinflammatory cytokine expression in islets

W Suarez-Pinzon, O Sorensen, RC Bleackley, JF Elliott, RV Rajotte and A Rabinovitch
Department of Medicine, University of Alberta, Edmonton, Canada.

A mechanism of autoimmune destruction of islet beta-cells in type 1 diabetes has been proposed to be the binding of Fas ligand (FasL) on T-cells to Fas receptors on beta-cells. We investigated this proposal by examining the expression of FasL and Fas on islet-infiltrating T-cells and beta-cells in relation to beta-cell destruction in a syngeneic islet transplant model in NOD mice. Diabetic NOD mice were transplanted with syngeneic islets and injected with complete Freund's adjuvant, which prevented diabetes recurrence (nondestructive insulitis), and with phosphate-buffered saline, which did not (beta-cell destructive insulitis). Two-color immunohistochemical assays revealed that FasL was expressed on CD4+ T-cells, CD8+ T-cells, and beta-cells in islet grafts from both diabetic and normoglycemic mice, and the percentage of each type of cell that expressed FasL was greater in islet grafts from normoglycemic compared with diabetic mice. In contrast, Fas was expressed on CD4+ T-cells, CD8+ T-cells, and beta-cells in islet grafts from diabetic mice, but it was nearly or totally absent on these cells in islet grafts from normoglycemic mice. Similarly, polymerase chain reaction analysis of islet grafts revealed that Fas mRNA expression was significantly lower in islet grafts from normoglycemic compared with diabetic mice. Also, mRNA levels of interleukin (IL)-1alpha, tumor necrosis factor (TNF)-alpha, and interferon (IFN)-gamma were significantly lower in islet grafts from normoglycemic mice. Finally, Fas was induced on NOD islet cells by incubation with IL-1beta, IFN-gamma, and the combination of IL-1beta, TNF-alpha, and IFN-gamma. These findings support the concept that cytokine-induced Fas receptor expression on islet beta-cells is a mechanism for their destruction by FasL-expressing CD4+ and CD8+ T-cells and, possibly, by FasL-expressing beta-cells themselves.
Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
D. Mokhtari, J. W. Myers, and N. Welsh
MAPK Kinase Kinase-1 Is Essential for Cytokine-Induced c-Jun NH2-Terminal Kinase and Nuclear Factor-{kappa}B Activation in Human Pancreatic Islet Cells
Diabetes, July 1, 2008; 57(7): 1896 - 1904.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
J. A. Emamaullee and A.M. J. Shapiro
Interventional Strategies to Prevent {beta}-Cell Apoptosis in Islet Transplantation.
Diabetes, July 1, 2006; 55(7): 1907 - 1914.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
X. Cao, J. Yang, B. R. Burkhardt, Z. Gao, R. K. Wong, S. R. Greene, J. Wu, and B. A. Wolf
Effects of overexpression of pancreatic derived factor (FAM3B) in isolated mouse islets and insulin-secreting {beta}TC3 cells
Am J Physiol Endocrinol Metab, October 1, 2005; 289(4): E543 - E550.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Wei, K. Chen, G. C. Sharp, and H. Braley-Mullen
Fas Ligand Is Required for Resolution of Granulomatous Experimental Autoimmune Thyroiditis
J. Immunol., December 15, 2004; 173(12): 7615 - 7621.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. Augstein, P. Heinke, E. Salzsieder, S. Berg, R. Rettig, C. Salzsieder, and L. C. Harrison
Fas Ligand Down-Regulates Cytokine-Induced Fas Receptor Expression on Insulinoma (NIT-1), But Not Islet Cells, from Autoimmune Nonobese Diabetic Mice
Endocrinology, June 1, 2004; 145(6): 2747 - 2752.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
B. Kutlu, A. K. Cardozo, M. I. Darville, M. Kruhoffer, N. Magnusson, T. Orntoft, and D. L. Eizirik
Discovery of Gene Networks Regulating Cytokine-Induced Dysfunction and Apoptosis in Insulin-Producing INS-1 Cells
Diabetes, November 1, 2003; 52(11): 2701 - 2719.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
X. Cao, Z. Gao, C. E. Robert, S. Greene, G. Xu, W. Xu, E. Bell, D. Campbell, Y. Zhu, R. Young, et al.
Pancreatic-Derived Factor (FAM3B), a Novel Islet Cytokine, Induces Apoptosis of Insulin-Secreting {beta}-Cells
Diabetes, September 1, 2003; 52(9): 2296 - 2303.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
R. Darwiche, M. M. W. Chong, P. Santamaria, H. E. Thomas, and T. W. H. Kay
Fas Is Detectable on {beta} Cells in Accelerated, But Not Spontaneous, Diabetes in Nonobese Diabetic Mice
J. Immunol., June 15, 2003; 170(12): 6292 - 6297.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. G. Silva, N. Petrovsky, L. Socha, R. Slattery, P. Gatenby, and B. Charlton
Mechanisms of Accelerated Immune-Mediated Diabetes Resulting from Islet {beta} Cell Expression of a Fas Ligand Transgene
J. Immunol., May 15, 2003; 170(10): 4996 - 5002.
[Abstract] [Full Text] [PDF]


Home page
Recent Prog Horm ResHome page
T. Hayashi and D. L. Faustman
Role of Defective Apoptosis in Type 1 Diabetes and Other Autoimmune Diseases
Recent Prog. Horm. Res., January 1, 2003; 58(1): 131 - 153.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Nakayama, M. Nagata, H. Yasuda, K. Arisawa, R. Kotani, K. Yamada, S. A. Chowdhury, S. Chakrabarty, Z. Z. Jin, H. Yagita, et al.
Fas/Fas Ligand Interactions Play an Essential Role in the Initiation of Murine Autoimmune Diabetes
Diabetes, May 1, 2002; 51(5): 1391 - 1397.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. Liu, A. K. Cardozo, M. I. Darville, and D. L. Eizirik
Double-Stranded RNA Cooperates with Interferon-{gamma} and IL-1{beta} to Induce Both Chemokine Expression and Nuclear Factor-{kappa}B-Dependent Apoptosis in Pancreatic {beta}-Cells: Potential Mechanisms for Viral-Induced Insulitis and {beta}-Cell Death in Type 1 Diabetes Mellitus
Endocrinology, April 1, 2002; 143(4): 1225 - 1234.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
H. Heimberg, Y. Heremans, C. Jobin, R. Leemans, A. K. Cardozo, M. Darville, and D. L. Eizirik
Inhibition of Cytokine-Induced NF-{kappa}B Activation by Adenovirus-Mediated Expression of a NF-{kappa}B Super-Repressor Prevents {beta}-Cell Apoptosis
Diabetes, October 1, 2001; 50(10): 2219 - 2224.
[Abstract] [Full Text]


Home page
DiabetesHome page
A. Pileggi, R. D. Molano, T. Berney, P. Cattan, C. Vizzardelli, R. Oliver, C. Fraker, C. Ricordi, R. L. Pastori, F. H. Bach, et al.
Heme Oxygenase-1 Induction in Islet Cells Results in Protection From Apoptosis and Improved In Vivo Function After Transplantation
Diabetes, September 1, 2001; 50(9): 1983 - 1991.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. I. Darville and D. L. Eizirik
Cytokine Induction of Fas Gene Expression in Insulin-Producing Cells Requires the Transcription Factors NF-{kappa}B and C/EBP
Diabetes, August 1, 2001; 50(8): 1741 - 1748.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. Liu, M. Darville, and D. L. Eizirik
Double-Stranded Ribonucleic Acid (RNA) Induces {beta}-Cell Fas Messenger RNA Expression and Increases Cytokine-Induced {beta}-Cell Apoptosis
Endocrinology, June 1, 2001; 142(6): 2593 - 2599.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. M. Larsen, S.J. Fey, M.R. Larsen, A. Nawrocki, H.U. Andersen, H. Kähler, C. Heilmann, M.C. Voss, P. Roepstorff, F. Pociot, et al.
Proteome Analysis of Interleukin-1{beta}-Induced Changes in Protein Expression in Rat Islets of Langerhans
Diabetes, May 1, 2001; 50(5): 1056 - 1063.
[Abstract] [Full Text]


Home page
DiabetesHome page
S. DeFranco, S. Bonissoni, F. Cerutti, G. Bona, F. Bottarel, F. Cadario, A. Brusco, G. Loffredo, I. Rabbone, A. Corrias, et al.
Defective Function of Fas in Patients With Type 1 Diabetes Associated With Other Autoimmune Diseases
Diabetes, March 1, 2001; 50(3): 483 - 488.
[Abstract] [Full Text]


Home page
J. Immunol.Home page
A. S. Diamond and R. G. Gill
An Essential Contribution by IFN-{gamma} to CD8+ T Cell-Mediated Rejection of Pancreatic Islet Allografts
J. Immunol., July 1, 2000; 165(1): 247 - 255.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
S. Kim, K.-A. Kim, D.-Y. Hwang, T. H. Lee, N. Kayagaki, H. Yagita, and M.-S. Lee
Inhibition of Autoimmune Diabetes by Fas Ligand: The Paradox Is Solved
J. Immunol., March 15, 2000; 164(6): 2931 - 2936.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
X. Su, Q. Hu, J. M. Kristan, C. Costa, Y. Shen, D. Gero, L. A. Matis, and Y. Wang
Significant Role for Fas in the Pathogenesis of Autoimmune Diabetes
J. Immunol., March 1, 2000; 164(5): 2523 - 2532.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. E. Thomas, R. Darwiche, J. A. Corbett, and T. W. H. Kay
Evidence That {beta} Cell Death in the Nonobese Diabetic Mouse Is Fas Independent
J. Immunol., August 1, 1999; 163(3): 1562 - 1569.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 1999 by the American Diabetes Association.